Potential role of rivaroxaban in patients with acute coronary syndrome

Patients with acute coronary syndrome (ACS) continue to be at risk for recurrent ischemic events, despite an early invasive strategy and the use of dual antiplatelet therapy. The anticoagulant pathway remains activated for a prolonged period after ACS and, consequently, has been a target for treatme...

Descripción completa

Detalles Bibliográficos
Autor principal: Fitchett, David H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509996/
https://www.ncbi.nlm.nih.gov/pubmed/23209364
http://dx.doi.org/10.2147/DDDT.S30342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3509996/
https://www.ncbi.nlm.nih.gov/pubmed/23209364
http://dx.doi.org/10.2147/DDDT.S30342

Ejemplares similares